L26, have you seen the two valuations on the CBio Web site?
Available here:
http://www.cbio.com.au/investors/research_reports.htm
They have price targets of 82c and $1.47, but this has some fairly conservative estimates, including a 50% probability that they have a sucessful Phase 2 trial. So assuming the trial is good, these price targets would double.
On a separate issue, has anyone recieved correspondence from the parties that have been given the list of CBZ shareholder details? I was about to send off my proxy form but would like to see what they have to say first.
Cheers,
redfloyd
Add to My Watchlist
What is My Watchlist?